Clinical shorts

Kelsall, Diane
June 2011
CMAJ: Canadian Medical Association Journal;6/14/2011, Vol. 183 Issue 9, p1051
Academic Journal
The article offers information related to medical research. It says that the anticholinergic agent tiotropium is more effective in preventing exacerbation in patients with moderate- to-severe chronic obstructive pulmonary disease (COPD). It adds that the perioperative myocardial infarction (MI) of patient in noncardiac surgery have no isehemic symptoms. Moreover, the genital shedding of herpes simplex virus type 2 (HSV-2) is more common in symptomatic people.


Related Articles

  • Inhaled anticholinergics for COPD. Tanzi, Maria G. // Pharmacy Today;Dec2008, Vol. 14 Issue 12, p23 

    The article presents a study concerning the effectiveness of the inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) treatment. Research shows that anticholinergics such as ipratropium and tiotropium were associated with increased risk for cardiovascular death in patients...

  • Tiotropium for uncontrolled asthma.  // Neurology Alert;Dec2010 Supplement, p1 

    The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).

  • Tiotropium for Uncontrolled Asthma.  // Internal Medicine Alert;12/15/2010 Clinical Briefs, p1 

    The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.

  • New treatment for COPD launched.  // Pulse;9/9/2002, Vol. 62 Issue 34, p4 

    Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.

  • Long-Term Azithromycin for Prophylaxis of COPD Exacerbations. Kuritzky, Louis // Neurology Alert;Nov2011 Clinical Briefs, p22 

    The article offers brief information on a study by R. K. Albert which indicates potential favorable effects of azithromycin prophylaxis in patients with acute exacerbations of moderate-severe chronic obstructive pulmonary disease (AECOPD).

  • Review Article. Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations. Lopez-Campos, Jose Luis; Jara-Palomares, Luis; Muñoz, Xavier; Bustamante, Víctor; Barreiro, Esther // Annals of Thoracic Medicine;Apr-Jun2015, Vol. 10 Issue 2, p87 

    Despite the overwhelming evidence justifying the use of non-invasive ventilation (NIV) for providing ventilatory support in chronic obstructive pulmonary disease (COPD) exacerbations, recent studies demonstrated that its application in real-life settings remains suboptimal. European clinical...

  • Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Critical Care Alert;Nov2008 Pharmacology Watch, p1 

    The article focuses on the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD).

  • Tiotropium cost effective in COPD in UK and Belgium.  // PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p7 

    The article discusses research on adding tiotropium to standard care that references the study "Cost-utility analysis of tiotropium versus usual care in patients with chronic obstructive pulmonary disease (COPD) in the U.K. and Belgium," by R. Hettle et al in the October 2012 issue of...

  • COMMENTARY. Niewoehner, Dennis E. // Evidence Based Medicine;May2003, p74 

    The author discusses aspects of drug effectiveness wherein he recommends that an anticholinergic agent can be combined with beta blocker agonist in the treatment pf patients with chronic obstructive pulmonary disease (COPD).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics